Skip to main content

Advertisement

SpringerLink
Log in

The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2′-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks

  • Original Article
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Although current evidence mainly suggests immunopathogenesis of demyelination and neurodegeneration in multiple sclerosis (MS), there are results which document the importance of other factors, such as oxidative stress and its mediated injuries. The oxidative stress intensity in axonal damage during acute demyelination is little known. We performed this study as a cross-sectional biomarker validation study in order to evaluate the parameters of axonal damage (phosphorylated neurofilaments heavy chain (pNF-H)) and oxidative stress (8-hydroxy-2′-deoxyguanosine (8-OHdG)) in plasma of patients with initial and relapsing-remitting demyelination attacks, defined as clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RRMS); and the correlations between these parameters and biological (index of blood brain barrier (BBB) permeability), clinical (index of disease progression), and radiological (T1-Gd-enhancing lesion volume) activities of disease. Both parameters were increased in CIS and RRMS compared to control subjects (p < 0.05). The positive correlations were observed between 8-OHdG values and index of BBB permeability, clinical severity of disease, and demyelinated brain lesion volume, in CIS group (r > 0.50; p < 0.05). Similar correlations were obtained between pNF-H values and the above parameters, as well as the index of disease progression, in RRMS group (r > 0.30; p < 0.05). There was a significant correlation between values of 8-OHdG and pNF-H only in CIS group, r = 0.52, p < 0.05. While the plasma values of 8-OHdG reflect the degree of acute demyelination in CIS, pNF-H values reflect that in RRMS. The obtained results must be reevaluated in similar prospective studies related to their prognostic values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Brettschneider J, Petzold A, Junker A, Tumani H (2006) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Multip Scler 12:143–148

    Article  CAS  Google Scholar 

  • Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, Sun J (2013) Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin Chim Acta 424:182–186

    Article  CAS  PubMed  Google Scholar 

  • Chang A, Tourtelotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med 346:165–173

    Article  PubMed  Google Scholar 

  • Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6:889–898

    Article  CAS  PubMed  Google Scholar 

  • Dale JM, Garcia ML (2012) Neurofilament phosphorylation during development and disease: which came first, the phosphorylation or the accumulation? J Amino Acids. doi:10.1155/2012/382107

    PubMed  PubMed Central  Google Scholar 

  • de Bock L, Fraussen J, Villar LM, Alvarez-Cermeno JC, van Wijmeersch B, van Pesch V, Stinissen P, Somers V (2016) Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index. Eur J Neurol 23:722–728

    Article  PubMed  Google Scholar 

  • Dutta R, Trapp BD (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93:1–12

    Article  PubMed  Google Scholar 

  • Eikelenboom MJ, Petzold A, Lazeron RH, Silber E, Sharief M, Thompson EJ, Barkhof F, Giovannoni G, Polman CH, Uitdehaag BM (2003) Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60:219–223

    Article  CAS  PubMed  Google Scholar 

  • Fressinaud C, Berges R, Eyer J (2012) Axon cytoskeleton proteins specifically modulate oligodendrocyte growth and differentiation in vitro. Neurochem Int 60:78–90

    Article  CAS  PubMed  Google Scholar 

  • Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225–238

    Article  CAS  PubMed  Google Scholar 

  • Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J (2011) Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 69:83–89

    Article  CAS  PubMed  Google Scholar 

  • Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914–1924

    Article  PubMed  PubMed Central  Google Scholar 

  • Jacob KD, Hooten NN, Trzeciak AR, Evans MK (2013) Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech Ageing Dev 134:139–157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung C, Lee S, Ortiz D, Zhu Q, Julien JP, Shea TB (2005) The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Mol Brain Res 141(2):151–155

    Article  CAS  PubMed  Google Scholar 

  • Koch MW, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253:483–487

    Article  CAS  PubMed  Google Scholar 

  • Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RL (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76:1206–1213

    Article  CAS  PubMed  Google Scholar 

  • Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452

    Article  CAS  PubMed  Google Scholar 

  • Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218

    Article  PubMed  Google Scholar 

  • Ljubisavljevic S (2016) Oxidative stress and neurobiology of demyelination. Mol Neurobiol 53(1):744–758

    Article  CAS  PubMed  Google Scholar 

  • Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey— National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911

    Article  CAS  PubMed  Google Scholar 

  • Medana IM, Esiri MM (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515–530

    Article  CAS  PubMed  Google Scholar 

  • Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233:183–198

    Article  CAS  PubMed  Google Scholar 

  • Petzold A, Eikelenboom MJ, Keir G, Grant D, Lazeron RHC, Polman CH, Uitdehaag BMJ, Thompson EJ, Giovannoni G (2005) Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry 76:206–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petzold A, Mondria T, Kuhle J, Rocca MA, Cornelissen J, te Boekhorst P, Lowenberg B, Giovannoni G, Filippi M, Kappos L, Hintzen R (2010) Evidence for acute neurotoxicity after chemotherapy. Ann Neurol 68:806–815

    Article  PubMed  Google Scholar 

  • Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302

    Article  PubMed  PubMed Central  Google Scholar 

  • Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G (2004) CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63:1439–1445

    Article  CAS  PubMed  Google Scholar 

  • Tasset I, Aguera E, Sánchez-López F, Feijóo M, Giraldo AI, Cruz AH, Gascón F, Túnez I (2012) Peripheral oxidative stress in relapsing–remitting multiple sclerosis. Clin Biochem 45:440–444

    Article  CAS  PubMed  Google Scholar 

  • Teunissen CE, Khalil M (2012) Neurofilaments as biomarkers inmultiple sclerosis. Mult Scler J 18(5):552–556

    Article  CAS  Google Scholar 

  • Turkez H, Togar B, Di Stefano A, Taspınar N, Sozio P (2015) Protective effects of cyclosativene on H2O2-induced injury in cultured rat primary cerebral cortex cells. Cytotechnology 67(2):299–309

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Grant from the scientific project number 41018 financed by the Ministry of Education and Science, Republic of Serbia. Authors thank Svetlana Stojanovic, Slobodan Vojinovic, and Dragan Stojanov, for the support in the laboratory, clinical, and radiological work.

Author information

Authors and Affiliations

  1. Clinic of Neurology, Clinical Center Nis, Bul. Dr Zorana Djindjica 48, 18000, Nis, Serbia

    S. Ljubisavljevic

  2. Faculty of Medicine, University of Nis, Bul. Dr Zorana Djindjica 81, 18000, Nis, Serbia

    S. Ljubisavljevic, I. Stojanovic, J. Basic & D. A. Pavlovic

Authors
  1. S. Ljubisavljevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Stojanovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Basic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. A. Pavlovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Ljubisavljevic.

Ethics declarations

Conflict of interest

No conflict of interest exists for any of the authors listed in the article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ljubisavljevic, S., Stojanovic, I., Basic, J. et al. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2′-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks. Neurotox Res 30, 530–538 (2016). https://doi.org/10.1007/s12640-016-9639-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-016-9639-z

Keywords

Search

Navigation